ArticleTherapeutics and clinical risk management2018

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients.

Chi-Chang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.